Nippon Shinyaku : UCB Japan Obtained Additional Application of Fintepla® (fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Japan -March 26, 2024 at 03:06 am EDT
NEWS RELEASE March 26, 2024 UCB Japan Obtained Additional Application of Fintepla® for the Treatment of Seizures...
Source: marketscreener.com